Category - Pharma Industry News
Juggling the regulatory complexities of global clinical trials
Greater tolerance: Allergic reactions to COVID vaccine lower for second dose
London High Court rules in favour of NHS in Servier drug dispute
Eli Lilly launches the Institute for Genetic Medicine and a $700m facility investment
Haleon days: GSK explains demerger decision
2022 pharma predictions
England to end COVID-19 isolation laws and mass free testing
COVID-19 booster to be made available to those over 75 and high risk adults and children